Elsevier

Ophthalmology

Volume 104, Issue 1, January 1997, Pages 7-21
Ophthalmology

The Five-year Incidence and Progression of Age-related Maculopathy: The Beaver Dam Eye Study

https://doi.org/10.1016/S0161-6420(97)30368-6Get rights and content

Purpose: The aim of the study was to describe the incidence and progression of retinal drusen, retinal pigmentary abnormalities, and signs of late age-related maculopathy.

Population: A population of 3583 adults (range, 43–86 years of age at baseline) living in Beaver Dam, Wisconsin, was studied during a 5-year period.

Methods: Characteristics of drusen and other lesions typical of age-related maculopathy were determined by grading stereoscopic color fundus photographs using the Wisconsin Age-Related Maculopathy Grading System.

Results: There was a statistically significant increased incidence of age-related maculopathy lesions with age (P < 0.05). Individuals 75 years of age or older had a significantly (P < 0.01) higher 5-year incidence of the following characteristics than people 43 to 54 years of age: larger sized drusen (125–249 μm,17.6% vs. 2.1 %; ≥ 250 μm, 6.5% vs. 0.2%), soft indistinct drusen (16.3% vs.1.8%), retinal pigment abnormalities (12.9% vs. 0.9%), exudative macular degeneration (1.8% vs. 0%), and pure geographic atrophy (1.7% vs. 0%). After adjusting for age, the incidence of early age-related maculopathy was 2.2 times (95% confidence interval 1.6, 3.2) as likely in women 75 years of age or older compared with men this age. At follow-up, late age-related macular degeneration was more likely to develop in eyes with soft indistinct drusen (6.5% vs. 0.1%) or retinal pigmentary abnormalities (7.1% vs. 0.1%) at baseline than in eyes without these lesions.

Conclusions: These population-based estimates document the high incidence of signs of age-related maculopathy in people 75 years of age or older, and in women compared with men that age. The findings demonstrate that the presence of soft drusen and pigmentary abnormalities significantly increases the risk for the development of geographic atrophy and exudative macular degeneration.

References (46)

  • JR Vingerling et al.

    The prevalence of age-related maculopathy in the Rotterdam Study

    Ophthalmology

    (1995)
  • P Mitchell et al.

    Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study

    Ophthalmology

    (1995)
  • NM Bressler et al.

    Age-related macular degeneration

    Surv Ophthalmol

    (1988)
  • GS Martinez et al.

    Prevalence of ocular disease in a population study of subjects 65 years old and older

    Am J Ophthalmol

    (1982)
  • R Klein et al.

    Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Survey

    Ophthalmology

    (1995)
  • JA Tielsch
  • HM Leibowitz et al.

    The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975

    Surv Ophthalmol

    (1980)
  • JP Ganley et al.

    Eye conditions and related need for medical care among persons 1–74 years of age: United States, 1971-72. Vital and Health Statistics. Series 11

    (1983)
  • A Sommer et al.

    Racial differences in the cause-specific prevalence of blindness in east Baltimore

    N Engl J Med

    (1991)
  • R Klein et al.

    The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity

    Invest Ophthalmol Vis Sci

    (1995)
  • JDM Gass

    Drusen and disciform macular detachment and degeneration

    Arch Ophthalmol

    (1973)
  • Z Gregor et al.

    Senile disciform macular degeneration in the second eye

    Br J Ophthalmol

    (1977)
  • ER Strahlman et al.

    The second eye of patients with senile macular degeneration

    Arch Ophthalmol

    (1983)
  • Cited by (0)

    Supported by National Institutes of Health grant EY06594 (Drs. R. Klein and B. E. K. Klein) and in part by the Research to Prevent Blindness (Senior Scientific Investigator Award, Dr. R. Klein), New York, New York. The authors have no proprietary interest in any of the products or equipment mentioned in this article.

    View full text